Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2003
09/18/2003WO2003076400A1 New inhibitors of histone deacetylase
09/18/2003WO2003076399A1 Compounds capable of inhibiting immunocyte-related allergic immune reactions
09/18/2003WO2003076398A2 Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors
09/18/2003WO2003076397A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003WO2003076395A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076393A1 Salts of nateglinide
09/18/2003WO2003076389A1 Compositions and methods for inhibition of phospholipase a2 mediated inflammation
09/18/2003WO2003076388A2 Bis-aniline derivatives useful as potassium channels modulators
09/18/2003WO2003076379A1 Alkoxy-substituted indanes and the production thereof
09/18/2003WO2003075982A1 Multiple compartment bag assembly for dialysis fluid
09/18/2003WO2003075959A1 Matrix metalloproteinase inhibitors in combination with hypothermia and/or radiotherapy for the treatment of cancer
09/18/2003WO2003075958A1 Remedies for sex hormone-dependent disease
09/18/2003WO2003075957A1 The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
09/18/2003WO2003075953A2 Immunomodulatory polymeric antigens for treating inflammatory pathogies
09/18/2003WO2003075952A1 Methods of enhancing immune induction involving mda-7
09/18/2003WO2003075947A1 Use of egfr transactivation inhibitors in human cancer
09/18/2003WO2003075945A2 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis
09/18/2003WO2003075943A2 Botanical extract compositions with anti-cancer or phytoestrogenic activity comprising wogonin, isoliquiritigenin and/or coumestrol
09/18/2003WO2003075939A1 Soybean saponin-containing material and process for producing the same
09/18/2003WO2003075938A1 Coumarins extractions and their uses for treating hypertension disease
09/18/2003WO2003075935A1 Drugs containing riboflavin-type compounds
09/18/2003WO2003075933A1 Composition for reducing blood glucose and cholesterol
09/18/2003WO2003075932A1 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
09/18/2003WO2003075931A1 A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus
09/18/2003WO2003075930A1 Synergistic enhancement of cognitive ability
09/18/2003WO2003075929A1 Inhibitors of histone deacetylase
09/18/2003WO2003075928A2 Stable pharmaceutical compositions
09/18/2003WO2003075927A1 Pharmaceutical combination of artesunate and mefloquine for therapy of malaria
09/18/2003WO2003075926A1 Use of proton pump inhibitors for the treatment of airway disorders
09/18/2003WO2003075925A1 Methods for reducing body fat and increasing a lean body mass by reducing stearoyl-coa desaturase 1 activity
09/18/2003WO2003075924A1 Heterocyclic amide derivatives for the treatment of diabetes and other diseases
09/18/2003WO2003075923A1 Vdac regulator
09/18/2003WO2003075921A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
09/18/2003WO2003075920A1 Eye drops containing tetrazole derivative
09/18/2003WO2003075919A1 Tablet containing pilsicainide hydrochloride (dry)
09/18/2003WO2003075918A1 Tablet containing pilsicainide hydrochloride (wet)
09/18/2003WO2003075917A1 Combination therapy for treating, preventing or managing proliferative disorders and cancers
09/18/2003WO2003075916A1 A non-hormonal approach to male contraception
09/18/2003WO2003075915A1 5-}2-hydroxy-3-`1-(3-trifluoromethylphenyl)-cyclopropyl!-propionylamino}- phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replacement therapy
09/18/2003WO2003075914A1 Citalopram for the treatment of elevated blood pressure
09/18/2003WO2003075913A1 Topical compostions comprising furfuryl derivatives and their use for the treatment of dermatologic disorders
09/18/2003WO2003075911A1 Use of ppar alpha agonists for the treatment of vascular and renal diseases
09/18/2003WO2003075910A1 Preventing and/or treating vascular disease, cardiomyopathy and/or associated heart failure
09/18/2003WO2003075909A1 Ibuprofen solution for hard shell capsules
09/18/2003WO2003075908A1 Use of adapalene for the treatment of dermatological disorders
09/18/2003WO2003075907A2 Small molecule entry inhibitors
09/18/2003WO2003075906A1 Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline
09/18/2003WO2003075905A1 Use of derivatives of 2,4-disubstituted phenols as inhibitors of the expression of l-selectins and of the isoform that is inducible from nitric oxide synthase
09/18/2003WO2003075904A2 Cyclodextrin complexed artemisinins
09/18/2003WO2003075903A2 Use proline and its functional equivalentsfor quenching ros and/ or radicals
09/18/2003WO2003075901A2 Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders
09/18/2003WO2003075900A2 Utilization of ubiquinones for influencing the effect of histamine
09/18/2003WO2003075899A2 Combinations comprising epothilone derivatives and alkylating agents
09/18/2003WO2003075896A1 Coated pharmaceutical single-unit delayed-release forms, based on polyvinyl acetate
09/18/2003WO2003075895A1 Tasted masked veterinary solid compositions
09/18/2003WO2003075893A1 Controlled release dosage forms
09/18/2003WO2003075892A1 Pharmaceutical microparticles
09/18/2003WO2003075890A1 Methods for entrapment of bioactive agent in a liposome or lipid complex
09/18/2003WO2003075889A1 An inhalation system for prevention and treatment of intracellular infections
09/18/2003WO2003075887A1 Sustained release drug formulations containing a carrier peptide
09/18/2003WO2003075884A1 Effervescent compositions comprising bisphosphonates and methods related thereto
09/18/2003WO2003075861A1 Antioxidative preparations
09/18/2003WO2003075858A2 Bicyclic heterocycles for the treatment of diabetes and other diseases
09/18/2003WO2003075857A2 Amino-methyl substituted tetracycline compounds
09/18/2003WO2003075856A2 Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea
09/18/2003WO2003075852A2 Antibiotic composition
09/18/2003WO2003075851A2 Compositions and methods for the treatment of anorectal disorders
09/18/2003WO2003075850A2 Methods for alzheimer's disease treatment and cognitive enhancement
09/18/2003WO2003075847A2 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
09/18/2003WO2003075842A2 Stable formulations of angiotensin converting enzyme (ace) inhibitors
09/18/2003WO2003075841A2 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
09/18/2003WO2003075839A2 Methods of inducing terminal differentiation
09/18/2003WO2003075836A2 Cathepsin cysteine protease inhibitors
09/18/2003WO2003075835A2 Compositions and methods for regulating thyroid hormone metabolism and cholesterol and lipid metabolism via the nuclear receptor car
09/18/2003WO2003075834A2 Activated protein c formulations
09/18/2003WO2003075832A2 Methods and composition based on discovery of metabolism of nitroclycerin
09/18/2003WO2003075830A2 Oral controlled drug delivery system containing carbamazepine
09/18/2003WO2003075829A2 Tasteless directly compressible fast-dissolving complexes and pharmaceutical formulations thereof
09/18/2003WO2003075828A2 Compounds useful in the treatment of cancer
09/18/2003WO2003075812A1 Controlled delivery patch of active ingredient
09/18/2003WO2003075741A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
09/18/2003WO2003075685A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
09/18/2003WO2003075670A1 Treatment and prevention of inflammatory disorders
09/18/2003WO2003075661A1 Oral formulations containing nucleotides that inhibit perception of unpleasant taste
09/18/2003WO2003075660A1 Method of treatment or prevention of obesity
09/18/2003WO2003075656A2 Nematicidal fatty acid and fatty acid ester related compounds
09/18/2003WO2003059973A3 Block copolymers
09/18/2003WO2003059296A3 Compositions comprising collagen and metalloprotease inhibitors
09/18/2003WO2003059283A3 Compounds for blocking androgen receptors
09/18/2003WO2003057163A3 Methods for preparing immunoconjugates
09/18/2003WO2003055444A3 Resveratrol analogues
09/18/2003WO2003053915A3 Compounds for the treatment of inflammatory disorders
09/18/2003WO2003053368A3 Chalcone derivatives and their use to treat diseases
09/18/2003WO2003053348A3 Direct osmotic hydration devices
09/18/2003WO2003051893A3 Improvements in pharmaceutical compositions
09/18/2003WO2003051838A3 Protein kinase inhibitors
09/18/2003WO2003051807A3 Improvements in pharmaceutical compositions
09/18/2003WO2003048122A3 Inhibitors of cytosolic phospholipase a2
09/18/2003WO2003047557A3 Device and patch for controlling the release of vanillin
09/18/2003WO2003047521A3 Composition and method for treatment of otitis media
1 ... 5336 5337 5338 5339 5340 5341 5342 5343 5344 5345 5346 5347 5348 5349 5350 5351 5352 5353 5354 5355 5356 ... 7860